Indications

Mesh Heading Maximum Phase Mesh ID Reference
Schizophrenia 3 D012559 ClinicalTrials
Carcinoma 3 D002277 ClinicalTrials
Adenomatous Polyposis Coli 3 D011125 ClinicalTrials
Diabetes Mellitus, Type 2 3 D003924 ClinicalTrials
Intestinal Diseases 3 D007410 ClinicalTrials
Atrial Fibrillation 3 D001281 ClinicalTrials
Cholestasis 3 D002779 ClinicalTrials
Infertility 3 D007246 ClinicalTrials
Metabolic Diseases 2 D008659 ClinicalTrials
Organophosphate Poisoning 2 D062025 ClinicalTrials
Reperfusion Injury 2 D015427 ClinicalTrials
Alzheimer Disease 2 D000544 ClinicalTrials
Respiratory Distress Syndrome 2 D012128 ClinicalTrials
Kernicterus 2 D007647 ClinicalTrials
Esophageal Atresia 2 D004933 ClinicalTrials
Obesity 1 D009765 ClinicalTrials
Abortion, Habitual 1 D000026 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 1 D064129 ClinicalTrials
Insulin Resistance 0 D007333 ClinicalTrials
Hypertension 0 D006973 ClinicalTrials

Related Entries

Mixture
Mixture
Mixture
Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
28.03
Cardiac disorders
9.05
Musculoskeletal and connective tissue disorders
8.85
Investigations
7.38
Injury, poisoning and procedural complications
7.22
Gastrointestinal disorders
7.18
Respiratory, thoracic and mediastinal disorders
6.78
Skin and subcutaneous tissue disorders
6.18
Vascular disorders
5.7
Nervous system disorders
3.19
Immune system disorders
2.67
Metabolism and nutrition disorders
2.23

Cross References

Resources Reference
ChEMBL CHEMBL1201485
FDA SRS 241ATL177A